Bruker Corp
BRKR
59.72
-0.78
-1.29%
Bruker Corp
US · BRKR
#1504 by market cap
Listed 1970
59.72
-0.78
-1.29%
Live - 5344 symbols - heartbeat 474s ago
· 2026-10-08 08:20
Pre-market
60.45
+1.22%
After-hours
60.45
+1.22%
Overnight
59.00
-1.21%
- Market cap
- 9.10B
- P/E (TTM)i
- -85.31
- P/Bi
- 3.79
- EPSi
- -0.15
- Div yieldi
- 0.33%
- 52W posi
- 79%
Reader sentiment
Are you bullish or bearish on BRKR?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Mixed / stable
- The number of reporting institutions decreased by 1 in the most recent period (2026/Q3).
- Total institutional ownership (as a % of shares) was little changed.
Institutional ownership
- Held by institutions
- 95.20% -0.01pp
- Institutions
- 494 -1
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund77.71%
Individual/Insider31.89%
Hedge Fund11.05%
Public Company2.67%
Government Pension Fund2.45%
Private Company0.87%
Sovereign Wealth Fund0.24%
Top holders as of 2026-08-15
Frank Laukien
26.53% · 40.42M sh
Orbis Investment Management Limited
11.77% · 17.94M sh
FMR
9.80% · 14.93M sh
BlackRock
7.49% · 11.41M sh
Pallas Capital Advisors LLC
6.22% · 9.48M sh
Joerg Laukien
4.93% · 7.52M sh
Vanguard Capital Management, LLC
3.65% · 5.56M sh
Strategic Advisers LLC
3.48% · 5.31M sh
Vanguard Portfolio Management, LLC
3.21% · 4.89M sh
Sculptor Capital Management, Inc.
3.04% · 4.63M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 26 buys · 23 sells
| Name | Role | Stake |
|---|---|---|
| Frank Laukien | Chairperson & CEO | 26.53% |
| Joerg Laukien | Former Director | 4.93% |
| Juergen Srega | President of Bruker CALID Group & Bruker Daltonics Division | 0.10% |
| Mark Munch | Corporate Executive VP and President of Bruker Nano Group & Corporate | 0.06% |
| Richard Packer | Independent Director | 0.06% |
| Gerald Herman | Chief Financial Officer | 0.04% |
| William Linton | Lead Independent Director | 0.04% |
| John Ornell | Independent Director | 0.02% |
| Robert Rosenthal | Independent Director | 0.02% |
| Falko Busse | President of Bruker BioSpin Group | 0.02% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-14 | Mark Munch | Corporate Executive VP and President of Bruker Nano Group & Corporate | Derivative Exercise and Sale | -2,000 | $22.19–52.87 |
| 2026-08-16 | Wolfgang Pusch | -- | Open Market Disposition | -3,473 | $56.90 |
| 2026-08-14 | Frank Laukien | Chairperson & CEO | Sale to Issuer | -4,760 | $57.70 |
| 2026-08-14 | Frank Laukien | Chairperson & CEO | Other Acquisition | +29,463 | -- |
| 2026-08-14 | Frank Laukien | Chairperson & CEO | Other Derivative Acquisition | +71,651 | $63.47 |
| 2026-08-14 | Mark Munch | Corporate Executive VP and President of Bruker Nano Group & Corporate | Sale to Issuer | -2,984 | $57.70 |
| 2026-08-14 | Mark Munch | Corporate Executive VP and President of Bruker Nano Group & Corporate | Other Acquisition | +14,443 | -- |
| 2026-08-14 | Mark Munch | Corporate Executive VP and President of Bruker Nano Group & Corporate | Other Derivative Acquisition | +11,708 | $57.70 |
| 2026-08-14 | Gerald Herman | Chief Financial Officer | Sale to Issuer | -2,724 | $57.70 |
| 2026-08-14 | Gerald Herman | Chief Financial Officer | Other Acquisition | +15,794 | -- |
| 2026-08-14 | Gerald Herman | Chief Financial Officer | Other Derivative Acquisition | +12,803 | $63.47 |
| 2026-08-14 | Burkhard Prause | President and CEO of Bruker Energy & Supercon Technologies, Inc. | Other Acquisition | +3,303 | -- |
| 2026-08-14 | Burkhard Prause | President and CEO of Bruker Energy & Supercon Technologies, Inc. | Other Derivative Acquisition | +2,678 | $57.70 |
| 2026-08-14 | Juergen Srega | President of Bruker CALID Group & Bruker Daltonics Division | Other Acquisition | +16,898 | -- |
| 2026-08-14 | Juergen Srega | President of Bruker CALID Group & Bruker Daltonics Division | Other Derivative Acquisition | +13,698 | $57.70 |
| 2026-08-14 | Thomas Bures | Chief Accounting Officer | Other Acquisition | +4,035 | -- |
| 2026-08-14 | Wolfgang Pusch | -- | Other Acquisition | +3,120 | -- |
| 2026-08-14 | Wolfgang Pusch | -- | Other Derivative Acquisition | +2,529 | $57.70 |
| 2026-08-13 | Mark Munch | Corporate Executive VP and President of Bruker Nano Group & Corporate | Derivative Exercise and Sale | -2,000 | $22.19–57.60 |
| 2026-08-10 | Frank Laukien | Chairperson & CEO | Sale to Issuer | -4,838 | $57.02 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 08:20:21 · For reference only, not investment advice and not tailored to your situation.